A2i Therapeutics secures seed funding from FutuRx and its investors - Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority ...
Israel's FutuRx, US-based Atomwise enter into strategic partnership The A2i Therapeutivs joint venture project will be funded by the Israeli Innovation Authority, FutuRx investors and addition ...
432HZ, the Argentine music label and company with areas devoted to leadership, music marketing and promotion and education, is launching its monthly FUTURX event. By Billboard Staff 432HZ, the ...
It may contain inaccuracies due to the limitations of machine translation. The process of cancer treatment through TNIK inhibition. Courtesy of the Korea Research Institute of Chemical Technology. The ...
Standing on a modestly sized black box stage, the Ciudad Juárez-born poet Jesús Valles muses on lost loves, juvenescence on both sides of the border, and the shooting this year that left 22 El Pasoans ...
At FutuRx, Johnson & Johnson Innovation, Takeda Ventures Inc. and OrbiMed teamed with the Office of the Chief Scientist of the Ministry of Economy in a national initiative dedicated to transforming ...
NESS-ZIONA, Israel, Jan. 12, 2020 /PRNewswire-PRWeb/ -- FutuRx, Israel's leading biopharmaceutical incubator, a partnership of OrbiMed Israel Partners, Johnson & Johnson Innovation - JJDC, and Takeda ...
Atomwise will help A2i screen more than 16 billion compounds for potential hits targeting a protein that helps control the body’s innate immune response, which may be wielded against cancer. (Pixabay) ...
FuturX is a five-day festival that celebrates the many permutations and intersections of LatinX identity in the 21st Century and beyond, featuring the works from playwrights, solo performers, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results